At Diagnopein Nashik, we use the latest COBAS TaqMan system for accurate, reproducible, and automated HBV DNA quantification. This enables early diagnosis, better
HBV-DNA PCR (Quantitative – COBAS TaqMan) is a precise molecular diagnostic test used to measure the amount of Hepatitis B virus (HBV) DNA in the blood. This advanced PCR (Polymerase Chain Reaction) technology is the gold standard for detecting and quantifying HBV viral load. Unlike routine Hepatitis B surface antigen (HBsAg) tests, which only confirm the presence of the virus, HBV-DNA PCR provides exact viral load measurements, helping doctors assess infection severity and make informed treatment decisions.
Hepatitis B is a serious liver infection that can progress to cirrhosis, liver failure, or liver cancer if left untreated. Quantitative HBV-DNA testing is crucial for:
Measuring Viral Load: Determines the level of HBV DNA in the blood to assess infection activity.
Guiding Treatment: Helps doctors decide when to start antiviral therapy.
Monitoring Therapy Response: Tracks how effectively medications are suppressing the virus.
Detecting Early Relapse: Identifies viral replication early, preventing further liver damage.
Using HBV-DNA PCR testing at Diagnopein Nashik ensures accurate and timely results that help manage Hepatitis B efficiently.
The HBV-DNA PCR test offers multiple advantages:
High Sensitivity: Detects very low levels of HBV DNA in blood.
Quantitative Results: Provides precise viral load measurements for treatment monitoring.
Reliable and Automated: COBAS TaqMan ensures consistent and reproducible results.
Treatment Guidance: Helps physicians customize antiviral therapy based on viral load trends.
Patient-Friendly: Requires a small blood sample and is minimally invasive.
At Diagnopein Nashik, patients benefit from advanced diagnostics, professional expertise, and reliable test results, enabling effective management of Hepatitis B.
HBV-DNA PCR testing is safe, quick, and accurate. The procedure at Diagnopein Nashik includes:
Blood Sample Collection: A small blood sample is drawn from the patient, typically from the arm.
DNA Extraction: HBV DNA is isolated from the blood using automated laboratory techniques.
PCR Amplification: The DNA is amplified using COBAS TaqMan technology for precise measurement.
Quantification: HBV viral load is reported in IU/mL, helping physicians monitor infection severity and treatment response.
Patients may be advised to fast if other tests are being performed simultaneously. The test is painless, quick, and provides highly reliable results.
HBV-DNA PCR quantifies viral load to help monitor disease and guide therapy:
Viral Load Measurement: Expressed in IU/mL (International Units per milliliter).
Sensitivity: Detects very low HBV DNA levels, often as low as 20 IU/mL.
Clinical Significance:
Low Viral Load: Indicates controlled infection.
High Viral Load: May require immediate antiviral therapy.
Regular follow-ups are recommended for patients undergoing antiviral therapy to assess the effectiveness of treatment.
Diagnopein Nashik offers advanced diagnostics with a patient-centered approach. Choosing us for HBV-DNA PCR (Quantitative – COBAS TaqMan) testing ensures:
Experienced medical professionals and trained laboratory technicians.
Quick sample processing with accurate, reproducible results.
Affordable and reliable testing using advanced COBAS TaqMan technology.
Comprehensive consultation and guidance based on test results.
Our focus on quality, precision, and patient care makes Diagnopein Nashik the preferred choice for Hepatitis B monitoring and management.
This test is crucial for confirming active Hepatitis B infection, monitoring viral load in chronic infections, guiding treatment decisions, and assessing the risk of liver disease.
A high HBV DNA level indicates active viral replication and may require immediate action, such as starting or adjusting antiviral therapy to reduce the risk of liver damage.
Generally, no special preparation is required, but your healthcare provider may provide specific instructions based on your situation.
A healthcare provider collects a blood sample from a vein in your arm. The sample is then sent to a laboratory for analysis using PCR methods to detect and quantify HBV DNA